Breast Cancer
Reports from J.R. Infante and colleagues advance knowledge in breast cancer
Published in Medicine and Law Weekly, May 8th, 2009
"Sixty patients with previously untreated, measurable HER2-positive MBC (immunohistochemistry 3+ and/or fluorescence in situ hybridization positive) were treated with docetaxel 30 mg/m(2) intravenously (I.V.) and vinorelbine 25 mg/m(2) I.V on days 1 and 8 of each 3-week cycle. Trastuzumab was given weekly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Chronic Disease
Scientists at University of Edinburgh target chronic disease - Cleft Palate
Research on cleft palate detailed by scientists at University Hospital - Craniocerebral Trauma
Research from University of Virginia, Medical Department reveals new findings on craniocerebral trauma - Diabetes Prevention
Researchers' work from University of Sydney, Center for Health Policy focuses on diabetes prevention - Diabetes Prevention
Studies from University of Sydney, Center for Health Policy add new findings in the area of diabetes prevention - DNA Research
Studies conducted at University of Virginia on DNA research recently published - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
